• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对21三体、18三体、13三体及X单体非侵入性产前检测的验证和临床经验研究的批判性评估

A Critical Evaluation of Validation and Clinical Experience Studies in Non-Invasive Prenatal Testing for Trisomies 21, 18, and 13 and Monosomy X.

作者信息

Demko Zachary, Prigmore Brittany, Benn Peter

机构信息

Natera, Inc., San Carlos, CA 94070, USA.

Department of Genetics and Genome Sciences, UConn Health, Farmington, CT 06030, USA.

出版信息

J Clin Med. 2022 Aug 15;11(16):4760. doi: 10.3390/jcm11164760.

DOI:10.3390/jcm11164760
PMID:36012999
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9410356/
Abstract

Non-invasive prenatal testing (NIPT) for trisomies 21, 18, 13 and monosomy X is widely utilized with massively parallel shotgun sequencing (MPSS), digital analysis of selected regions (DANSR), and single nucleotide polymorphism (SNP) analyses being the most widely reported methods. We searched the literature to find all NIPT clinical validation and clinical experience studies between January 2011 and January 2022. Meta-analyses were performed using bivariate random-effects and univariate regression models for estimating summary performance measures across studies. Bivariate meta-regression was performed to explore the influence of testing method and study design. Subgroup and sensitivity analyses evaluated factors that may have led to heterogeneity. Based on 55 validation studies, the detection rate (DR) was significantly higher for retrospective studies, while the false positive rate (FPR) was significantly lower for prospective studies. Comparing the performance of NIPT methods for trisomies 21, 18, and 13 combined, the SNP method had a higher DR and lower FPR than other methods, significantly so for MPSS, though not for DANSR. The performance of the different methods in the 84 clinical experience studies was consistent with validation studies. Clinical positive predictive values of all NIPT methods improved over the last decade. We conclude that all NIPT methods are highly effective for fetal aneuploidy screening, with performance differences across methodologies.

摘要

用于21三体、18三体、13三体和X单体的无创产前检测(NIPT)被广泛应用,其中大规模平行鸟枪法测序(MPSS)、选定区域数字分析(DANSR)和单核苷酸多态性(SNP)分析是报道最为广泛的方法。我们检索了文献,以查找2011年1月至2022年1月期间所有NIPT临床验证和临床经验研究。使用双变量随机效应模型和单变量回归模型进行荟萃分析,以估计各项研究的汇总性能指标。进行双变量元回归以探讨检测方法和研究设计的影响。亚组分析和敏感性分析评估了可能导致异质性的因素。基于55项验证研究,回顾性研究的检测率(DR)显著更高,而前瞻性研究的假阳性率(FPR)显著更低。比较21三体、18三体和13三体联合检测的NIPT方法性能,SNP方法的DR更高,FPR更低,与MPSS相比差异显著,但与DANSR相比差异不显著。84项临床经验研究中不同方法的性能与验证研究一致。在过去十年中,所有NIPT方法的临床阳性预测值均有所提高。我们得出结论,所有NIPT方法对胎儿非整倍体筛查都非常有效,但不同方法的性能存在差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdb/9410356/04f6356aa148/jcm-11-04760-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdb/9410356/84b423d9ec8a/jcm-11-04760-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdb/9410356/04f6356aa148/jcm-11-04760-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdb/9410356/84b423d9ec8a/jcm-11-04760-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbdb/9410356/04f6356aa148/jcm-11-04760-g002.jpg

相似文献

1
A Critical Evaluation of Validation and Clinical Experience Studies in Non-Invasive Prenatal Testing for Trisomies 21, 18, and 13 and Monosomy X.对21三体、18三体、13三体及X单体非侵入性产前检测的验证和临床经验研究的批判性评估
J Clin Med. 2022 Aug 15;11(16):4760. doi: 10.3390/jcm11164760.
2
Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.21、18和13三体综合征的无创产前检测:146958例妊娠的临床经验
Ultrasound Obstet Gynecol. 2015 May;45(5):530-8. doi: 10.1002/uog.14792. Epub 2015 Apr 8.
3
Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.母体血液游离 DNA 分析在非整倍体筛查中的应用:更新的荟萃分析。
Ultrasound Obstet Gynecol. 2017 Sep;50(3):302-314. doi: 10.1002/uog.17484. Epub 2017 Jul 27.
4
[Non invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing. Initial experience in Mexican women and literature review].[通过平行大规模测序检测孕妇血液中的无创产前检测(NIPT)。墨西哥女性的初步经验及文献综述]
Ginecol Obstet Mex. 2015 May;83(5):277-88.
5
Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.单中心无创性产前检测胎儿 13、18 和 21 三体的 Z 评分准确性评估。
Prenat Diagn. 2021 May;41(6):690-696. doi: 10.1002/pd.5908. Epub 2021 Feb 11.
6
The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis.基于游离胎儿 DNA 的无创性产前检测在单胎妊娠中的准确性:系统评价和双变量荟萃分析。
BJOG. 2017 Jan;124(1):32-46. doi: 10.1111/1471-0528.14050. Epub 2016 May 31.
7
Noninvasive prenatal testing in routine clinical practice for a high-risk population: Experience from a center.高危人群常规临床实践中的无创产前检测:来自一个中心的经验
Medicine (Baltimore). 2016 Oct;95(41):e5126. doi: 10.1097/MD.0000000000005126.
8
Single Nucleotide Polymorphism-Based Noninvasive Prenatal Testing: Experience in India.基于单核苷酸多态性的无创产前检测:印度的经验
J Obstet Gynaecol India. 2018 Dec;68(6):462-470. doi: 10.1007/s13224-017-1061-9. Epub 2018 Jan 25.
9
Validation of combinatorial probe-anchor ligation-based sequencing as non-invasive prenatal test for trisomy at a central laboratory.在中心实验室验证基于组合探针锚定连接的测序作为三体性非侵入性产前检测方法。
Ultrasound Obstet Gynecol. 2017 Jul;50(1):49-57. doi: 10.1002/uog.16010. Epub 2017 May 30.
10
Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.应用 IONA 测试的双胎妊娠游离胎儿 DNA 非侵入性产前筛查:一项前瞻性多中心研究。
Am J Obstet Gynecol. 2021 Jul;225(1):79.e1-79.e13. doi: 10.1016/j.ajog.2021.01.005. Epub 2021 Jan 15.

引用本文的文献

1
A Decade of Non-Invasive Prenatal Testing (NIPT) for Chromosomal Abnormalities in Croatia: First National Monocentric Study to Inform Country's Future Prenatal Care Strategy.克罗地亚十年无创产前检测(NIPT)用于染色体异常检测:为该国未来产前护理策略提供信息的首个全国单中心研究
Genes (Basel). 2024 Dec 11;15(12):1590. doi: 10.3390/genes15121590.
2
Cell-free placental DNA: What do we really know?游离胎盘DNA:我们究竟了解多少?
PLoS Genet. 2024 Dec 9;20(12):e1011484. doi: 10.1371/journal.pgen.1011484. eCollection 2024 Dec.
3
Donor-derived cell-free DNA-based liquid biopsies to determine future kidney transplant rejection.

本文引用的文献

1
Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.游离胎儿 DNA 筛查在唐氏综合征 21、18 和 13 三体的低危和高危妊娠中的应用,其结果得到了遗传学证实。
Am J Obstet Gynecol. 2022 Aug;227(2):259.e1-259.e14. doi: 10.1016/j.ajog.2022.01.019. Epub 2022 Jan 25.
2
Genetic Counseling and Management: The First Study to Report NIPT Findings in a Romanian Population.遗传咨询和管理:第一项报告罗马尼亚人群 NIPT 结果的研究。
Medicina (Kaunas). 2022 Jan 5;58(1):79. doi: 10.3390/medicina58010079.
3
Cell-Free DNA Screening for Sex Chromosome Abnormalities and Pregnancy Outcomes, 2018-2020: A Retrospective Analysis.
基于供体游离DNA的液体活检用于确定未来肾移植排斥反应。
Kidney Res Clin Pract. 2025 Sep;44(5):705-725. doi: 10.23876/j.krcp.23.286. Epub 2024 Sep 13.
4
Approach and Management of Pregnancies with Risk Identified by Non-Invasive Prenatal Testing.无创产前检测识别出风险的妊娠的处理与管理
J Pers Med. 2024 Mar 29;14(4):366. doi: 10.3390/jpm14040366.
5
Non-invasive prenatal test findings in 41,819 pregnant women: results from a clinical laboratory in southern China.在中国南方的一家临床实验室中,对 41819 名孕妇进行了无创性产前检测结果分析。
Arch Gynecol Obstet. 2023 Sep;308(3):787-795. doi: 10.1007/s00404-022-06908-3. Epub 2023 Jan 5.
2018 - 2020年游离DNA筛查性染色体异常与妊娠结局:一项回顾性分析
J Pers Med. 2022 Jan 4;12(1):48. doi: 10.3390/jpm12010048.
4
Initial Clinical Experience with NIPT for Rare Autosomal Aneuploidies and Large Copy Number Variations.无创产前检测用于罕见常染色体非整倍体和大片段拷贝数变异的初步临床经验
J Clin Med. 2022 Jan 13;11(2):372. doi: 10.3390/jcm11020372.
5
The role of first-trimester ultrasound screening for women with positive noninvasive prenatal testing results.早孕期超声筛查在阳性无创产前筛查结果孕妇中的作用。
J Obstet Gynaecol Res. 2022 Feb;48(2):328-332. doi: 10.1111/jog.15115. Epub 2021 Dec 16.
6
Expanding the application of non-invasive prenatal testing in the detection of foetal chromosomal copy number variations.拓展无创产前检测在检测胎儿染色体拷贝数变异中的应用。
BMC Med Genomics. 2021 Dec 11;14(1):292. doi: 10.1186/s12920-021-01131-6.
7
Clinical Validation of Fetal cfDNA Analysis Using Rolling-Circle-Replication and Imaging Technology in Osaka (CRITO Study).大阪胎儿游离DNA分析的滚环复制及成像技术临床验证(CRITO研究)
Diagnostics (Basel). 2021 Oct 4;11(10):1837. doi: 10.3390/diagnostics11101837.
8
Cell-free DNA screening for fetal aneuploidy using the rolling circle method: A step towards non invasive prenatal testing simplification.基于滚环扩增方法的胎儿非整倍体细胞游离 DNA 筛查:向无创性产前检测简化迈出的一步。
Prenat Diagn. 2021 Dec;41(13):1694-1700. doi: 10.1002/pd.6050. Epub 2021 Oct 7.
9
Audit of the first > 7500 noninvasive prenatal aneuploidy tests in a Swiss genetics center.瑞士一家遗传学中心对首批超过7500例无创产前非整倍体检测的审核。
Arch Gynecol Obstet. 2022 May;305(5):1185-1192. doi: 10.1007/s00404-021-06203-7. Epub 2021 Sep 17.
10
Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.基于非下一代测序的无创性产前检测技术的评估及临床应用。
Curr Issues Mol Biol. 2021 Aug 17;43(2):958-964. doi: 10.3390/cimb43020068.